| Article | Date | Source |
|---|
| Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study | May 07, 2013 | Biotech News - PR Newswire |
| Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod | March 27, 2013 | Biotech News - PR Newswire |
| Anthera Pharmaceuticals, Inc. Reports 2012 Fourth Quarter and Fiscal Year Financial Results | March 27, 2013 | BioSpace - Breaking News |
| Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil | February 05, 2013 | Pharma News - PR Newswire |
| Anthera prepares for late-stage lupus drug trials | September 17, 2012 | Health News - CNBC |
| Anthera Pharmaceuticals, Inc. Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE) | September 17, 2012 | BioSpace - Breaking News |
| Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE) | September 17, 2012 | Pharma News - PR Newswire |
| Anthera to Report Second Quarter 2012 Financial Results | August 01, 2012 | Biotech News - PR Newswire |
| Anthera Pharmaceuticals, Inc. Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population | July 16, 2012 | BioSpace - Breaking News |
| Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population | July 16, 2012 | Biotech News - PR Newswire |
| Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference | July 09, 2012 | Biotech News - PR Newswire |
| Primary Goal Not Met in Anthera Pharmaceuticals, Inc.'s Lupus Drug Study | June 28, 2012 | BioSpace |
| In fresh setback Anthera shares blitzed as lupus drug flunks PhIIb | June 28, 2012 | FierceBiotech |
| Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod | June 27, 2012 | Biotech News - PR Newswire |
| Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update | May 03, 2012 | Biotech News - PR Newswire |
| Anthera Pharmaceuticals to Present at the BioCentury Future Leaders Conference | April 17, 2012 | Pharma News - PR Newswire |
| Anthera lays off 45% of workforce, focuses on lupus | March 19, 2012 | Health News - BizJournals.com |
| Anthera slashes jobs over failed cardiac trial, shifts focus to lupus drug | March 19, 2012 | FierceBiotech |
| Anthera Pharmaceuticals, Inc. to Cut Almost Half of its Workforce | March 16, 2012 | BioSpace - Breaking News |
| Anthera Provides Corporate Update on Recent Activities | March 15, 2012 | Pharma News - PR Newswire |
| Anthera Pharmaceuticals, Inc. Tanks as it Halts Phase III VISTA-16 Heart Drug Trial; Stock Falls -3.0750(47.90%) @ 10:05AM EDT | March 12, 2012 | BioSpace |
| Anthera shares collapse on halt of Phase III cardio trial | March 12, 2012 | FierceBiotech |
| Anthera shares collapse on halt of Ph3 cardio trial | March 12, 2012 | FierceBiotech |
| Anthera Pharma ends trial of cardiovascular drug | March 09, 2012 | Health News - CNBC |
| Anthera Halts VISTA-16 Clinical Study Due to Lack of Efficacy Following Recommendation by the Independent Data Safety Monitoring Board | March 09, 2012 | Biotech News - PR Newswire |
| Anthera Pharmaceuticals to Present at the Citi Global Health Care Conference | February 23, 2012 | Biotech News - PR Newswire |
| Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update | February 21, 2012 | Pharma News - PR Newswire |
| Ipsen hands back Parkinson's drug rights to Santhera | January 24, 2012 | FierceBiotech |
| Santhera Pharmaceuticals AG and Ipsen Renegotiate Fipamezole Licensing Agreement | January 24, 2012 | BioSpace - Breaking News |
| Santhera and Ipsen announces renegotiated Fipamezole licensing agreement | January 24, 2012 | Pharmaceutical - Moreover |
| Santhera et Ipsen renégocient leur accord de licence sur le fipamezole | January 24, 2012 | Pharma News - Business Wire |
| Santhera and Ipsen Renegotiate Fipamezole Licensing Agreement | January 24, 2012 | Pharma News - Business Wire |
| Anthera Appoints Chief Technology Officer | December 06, 2011 | Contract Pharma |
| Anthera Pharmaceuticals Promotes Dr. Debra Odink to Chief Technology Officer(2) | December 06, 2011 | Pharmaceutical - Moreover |
| Anthera Pharmaceuticals, Inc. Completes Interim B-Cell Analysis of PEARL-SC Study | December 01, 2011 | BioSpace - Breaking News |
| Anthera Announces Last Patient Enrolled in PEARL-SC Study | October 25, 2011 | Pharma News - PR Newswire |
| Anthera Announces Third Quarter 2011 Financial Report and Conference Call | October 25, 2011 | Biotech News - PR Newswire |
